Dmitry Balyasny’s Mead Johnson Nutrition Company MJN Stock Holding History

Dmitry Balyasny’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-399,375	Closed	-$28.3M	–	1897
2016 Q4	$28.3M	Sell	399,375 -292,074	-42%	-$21.8M	0.15%	186
2016 Q3	$54.6M	Sell	691,449 -100,085	-13%	-$8.54M	0.32%	90
2016 Q2	$71.8M	Sell	791,534 -38,980	-5%	-$3.3M	0.47%	35
2016 Q1	$70.6M	Buy	+830,514	New	+$61.8M	0.42%	46
2015 Q4	–	Sell	-827,200	Closed	-$65.2M	–	1598
2015 Q3	$58.2M	Buy	827,200 +819,302	+10,374%	+$67.4M	0.43%	54
2015 Q2	$713K	Buy	+7,898	New	+$762K	﹤0.01%	828
2014 Q4	–	Sell	-385,489	Closed	-$37.1M	–	944
2014 Q3	$37.1M	Buy	385,489 +370,917	+2,545%	+$35.1M	0.29%	72
2014 Q2	$1.36M	Sell	14,572 -353,327	-96%	-$30.9M	0.02%	569
2014 Q1	$30.6M	Buy	+367,899	New	+$29.8M	0.35%	72

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dmitry Balyasny's MJN Position: Q1 2017 in Review

Dmitry Balyasny sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 399,375 shares — an estimated $28.3M sold.

Dmitry Balyasny first reported a position in MJN in Q1 2014 and held it in 9 quarters. The position peaked at $71.8M in Q2 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

Dmitry Balyasny reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
Dmitry Balyasny sold 399,375 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $28.3M.
Dmitry Balyasny first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 9 quarters.
Dmitry Balyasny's Mead Johnson Nutrition Company position peaked at $71.8M in Q2 2016.
533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Balyasny Asset Management's 13F filing for Q1 2017, filed 15 May 2017.